Start or Switch?: Latest data from ABCSG/ARNO Adjuvant endocrine therapy for early breast cancer Recent trial data has challenged tamoxifen’s position as the gold standard…
CARCINOMA DELLA MAMMELLA UPDATE FROM AROMATASE INHIBITORS STUDIES AT OCTOBER 2006 ANASTROZOLE (A), LETROZOLE (L), EXEMESTANE (E) What’s really new in endocrine therapy…